GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (LTS:0HRT) » Definitions » Shiller PE Ratio

CV Sciences (LTS:0HRT) Shiller PE Ratio : (As of May. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is CV Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CV Sciences Shiller PE Ratio Historical Data

The historical data trend for CV Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Shiller PE Ratio Chart

CV Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CV Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CV Sciences's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CV Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CV Sciences's Shiller PE Ratio falls into.


;
;

CV Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CV Sciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, CV Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/133.1571*133.1571
=0.000

Current CPI (Dec. 2024) = 133.1571.

CV Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.080 99.621 -0.107
201506 -0.060 100.684 -0.079
201509 -0.030 100.392 -0.040
201512 -0.190 99.792 -0.254
201603 -0.030 100.470 -0.040
201606 -0.040 101.688 -0.052
201609 -0.040 101.861 -0.052
201612 -0.160 101.863 -0.209
201703 -0.060 102.862 -0.078
201706 -0.010 103.349 -0.013
201709 -0.010 104.136 -0.013
201712 0.010 104.011 0.013
201803 0.010 105.290 0.013
201806 0.030 106.317 0.038
201809 0.030 106.507 0.038
201812 0.030 105.998 0.038
201903 -0.100 107.251 -0.124
201906 0.010 108.070 0.012
201909 -0.020 108.329 -0.025
201912 -0.070 108.420 -0.086
202003 -0.050 108.902 -0.061
202006 -0.050 108.767 -0.061
202009 -0.030 109.815 -0.036
202012 -0.090 109.897 -0.109
202103 -0.030 111.754 -0.036
202106 -0.030 114.631 -0.035
202109 0.000 115.734 0.000
202112 -0.080 117.630 -0.091
202203 -0.020 121.301 -0.022
202206 -0.030 125.017 -0.032
202209 -0.010 125.227 -0.011
202212 -0.020 125.222 -0.021
202303 0.040 127.348 0.042
202306 -0.010 128.729 -0.010
202309 -0.003 129.860 -0.003
202312 -0.010 129.419 -0.010
202403 -0.004 131.776 -0.004
202406 -0.003 132.554 -0.003
202409 -0.003 133.029 -0.003
202412 0.000 133.157 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CV Sciences  (LTS:0HRT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CV Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CV Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CV Sciences Business Description

Traded in Other Exchanges
Address
9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126
CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The Company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, lusHLTH, Cultured Foods, and Lunar Fox. The Company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company's hemp-based products are predominantly sold in Europe and in the retail space. The company generates revenue from Retail Sales and E-Commerce sales of its product.

CV Sciences Headlines

No Headlines